These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

498 related articles for article (PubMed ID: 17132404)

  • 61. Management of nonalcoholic steatohepatitis: an evidence-based approach.
    Mahady SE; George J
    Clin Liver Dis; 2012 Aug; 16(3):631-45. PubMed ID: 22824485
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Pathogenesis of non-alcoholic steatohepatitis: human data.
    Edmison J; McCullough AJ
    Clin Liver Dis; 2007 Feb; 11(1):75-104, ix. PubMed ID: 17544973
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Nonalcoholic steatohepatitis: recent advances from experimental models to clinical management.
    Portincasa P; Grattagliano I; Palmieri VO; Palasciano G
    Clin Biochem; 2005 Mar; 38(3):203-17. PubMed ID: 15708540
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Nonalcoholic fatty liver disease and bariatric surgery.
    Stephen S; Baranova A; Younossi ZM
    Expert Rev Gastroenterol Hepatol; 2012 Apr; 6(2):163-71. PubMed ID: 22375522
    [TBL] [Abstract][Full Text] [Related]  

  • 65. A critical appraisal of advances in pediatric nonalcoholic Fatty liver disease.
    Ovchinsky N; Lavine JE
    Semin Liver Dis; 2012 Nov; 32(4):317-24. PubMed ID: 23397532
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Diagnosis of and therapy for nonalcoholic steatohepatitis].
    Onishi S; Saibara T
    Nihon Naika Gakkai Zasshi; 2006 Sep; 95(9):1876-80. PubMed ID: 17037330
    [No Abstract]   [Full Text] [Related]  

  • 67. Review: nonalcoholic steatohepatitis.
    Ludwig J; McGill DB; Lindor KD
    J Gastroenterol Hepatol; 1997 May; 12(5):398-403. PubMed ID: 9195388
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Predictors of nonalcoholic steatohepatitis in patients undergoing bariatric surgery: when is liver biopsy indicated?
    Helling TS; Helzberg JH; Nachnani JS; Gurram K
    Surg Obes Relat Dis; 2008; 4(5):612-7. PubMed ID: 18226970
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Expression of genes encoding mitochondrial proteins can distinguish nonalcoholic steatosis from steatohepatitis.
    Bragoszewski P; Habior A; Walewska-Zielecka B; Ostrowski J
    Acta Biochim Pol; 2007; 54(2):341-8. PubMed ID: 17502923
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Prospective study of the long-term effects of bariatric surgery on liver injury in patients without advanced disease.
    Mathurin P; Hollebecque A; Arnalsteen L; Buob D; Leteurtre E; Caiazzo R; Pigeyre M; Verkindt H; Dharancy S; Louvet A; Romon M; Pattou F
    Gastroenterology; 2009 Aug; 137(2):532-40. PubMed ID: 19409898
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Nonalcoholic fatty liver disease and metabolic syndrome: a concise review.
    Streba LA; Cârstea D; Mitruţ P; Vere CC; Dragomir N; Streba CT
    Rom J Morphol Embryol; 2008; 49(1):13-20. PubMed ID: 18273497
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Non-alcoholic fatty liver disease in children: a new complication of obesity].
    Bocca G; Stolk RP; Scheenstra R; Sauer PJ
    Ned Tijdschr Geneeskd; 2008 Nov; 152(45):2443-7. PubMed ID: 19051794
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Molecular mechanisms and therapeutic targets in steatosis and steatohepatitis.
    Anderson N; Borlak J
    Pharmacol Rev; 2008 Sep; 60(3):311-57. PubMed ID: 18922966
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Nonalcoholic fatty liver disease.
    Angulo P
    Rev Gastroenterol Mex; 2005 Nov; 70 Suppl 3():52-6. PubMed ID: 17471859
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [Definition and management of non-alcoholic steatohepatitis (NASH)].
    Hütteroth TH
    Dtsch Med Wochenschr; 2001 Jun; 126 Suppl 1():S64-7. PubMed ID: 11450617
    [No Abstract]   [Full Text] [Related]  

  • 76. [Therapeuric aspects of NAFLD. A literature review].
    Tapia NC; Avila FI; Leiva JG; Ramos MH; Avila JF; Uribe M
    Rev Gastroenterol Mex; 2006; 71(4):487-95. PubMed ID: 17542283
    [TBL] [Abstract][Full Text] [Related]  

  • 77. A 2012 clinical update for internists in adult nonalcoholic fatty liver disease.
    Younossi ZM; Venkatesan C
    Panminerva Med; 2012 Mar; 54(1):29-37. PubMed ID: 22278114
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Nonalcoholic steatohepatitis (NASH)].
    Saibara T; Onishi S
    Nihon Shokakibyo Gakkai Zasshi; 2002 Jun; 99(6):570-6. PubMed ID: 12099001
    [No Abstract]   [Full Text] [Related]  

  • 79. Risk factors associated with nonalcoholic fatty liver disease and its relationship with the hepatic histological changes.
    Rodríguez-Hernández H; Gonzalez JL; Márquez-Ramirez MD; Flores-Hernandez M; Rodríguez-Morán M; Guerrero-Romero F
    Eur J Gastroenterol Hepatol; 2008 May; 20(5):399-403. PubMed ID: 18403941
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Noninvasive diagnosis and monitoring of nonalcoholic steatohepatitis: present and future.
    Wieckowska A; McCullough AJ; Feldstein AE
    Hepatology; 2007 Aug; 46(2):582-9. PubMed ID: 17661414
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.